Aligos Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aligos Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Aligos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $1.71M, a 34% decline year-over-year.
  • Aligos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $8.45M, a 33.2% decline year-over-year.
  • Aligos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $8.45M, a 33.2% decline from 2023.
  • Aligos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.7M, a 13.9% decline from 2022.
  • Aligos Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14.7M, a 9.19% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $8.45M -$4.2M -33.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 $12.7M -$2.04M -13.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 $14.7M +$1.24M +9.19% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 $13.5M +$10.5M +352% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $2.98M +$2.22M +296% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $752K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.